Varex equals 24% of Teledyne’s imaging sales, but its margin is less than half as high

Teledyne Technologies Incorporated (NYSE: TDY) is buying meaningful revenue with its proposed $1.1 billion acquisition of Varex Imaging Corporation (NASDAQ: VREX), but the less obvious number is profitability. Varex generated $211 million of revenue in its fiscal third quarter, equivalent to about 24.3% of the $868.7 million produced by Teledyne’s Digital Imaging segment in its latest quarter. Yet Varex reported a 12% non-GAAP operating margin, while Teledyne’s Digital Imaging business generated roughly 25.0%, meaning the acquired revenue currently carries less than half the operating profitability of the segment receiving it.

That margin difference creates a very different question from whether Teledyne is paying too much for photon-counting detectors, X-ray tubes and other imaging technology. The more important post-deal issue may be whether Teledyne can use its scale, product mix and operating discipline to move Varex closer to its own economics without disrupting a business that has only recently begun showing stronger profitability.

How much scale would Varex actually add to Teledyne Digital Imaging?

Teledyne’s Digital Imaging segment produced $868.7 million of second-quarter revenue, up 12.7% year over year, while non-GAAP operating income reached $217.6 million. That translates into a non-GAAP operating margin of approximately 25.0%, supported by stronger infrared imaging demand, surveillance products, industrial and scientific imaging systems and X-ray products.

Varex, meanwhile, reported $211 million of fiscal third-quarter sales, including $134 million from Medical and $77 million from Industrial. Revenue increased 4% year over year, while its non-GAAP gross margin rose to 37% and non-GAAP operating margin reached 12%. The quarter also contained a $7 million reduction to reported revenue associated with expected customer reimbursements following tariff refunds, meaning underlying product sales before that adjustment were approximately $217 million.

On the simplest latest-quarter comparison, Varex therefore represents roughly one-quarter of Teledyne’s existing Digital Imaging revenue base. That is large enough for the acquisition to matter operationally rather than functioning as a small technology tuck-in.

What happens to Teledyne’s 25% imaging margin if Varex is simply added?

A mechanical combination illustrates the integration challenge. Applying Varex’s disclosed 12% non-GAAP operating margin to its $211 million quarterly revenue implies approximately $25.3 million of non-GAAP operating profit. Adding that to Teledyne Digital Imaging’s $217.6 million would produce roughly $242.9 million of combined operating income on about $1.08 billion of sales.

The resulting illustrative margin is approximately 22.5%, around 255 basis points below Teledyne Digital Imaging’s current 25.0% level. This is not a forecast because it ignores purchase accounting, cost savings, revenue synergies, financing effects and differences between the companies’ reporting periods. It does, however, show why Varex’s margin trajectory may matter almost as much as its technology portfolio after closing.

The opportunity is that Teledyne does not necessarily need Varex to reach 25% immediately. Even partial margin convergence across a business generating more than $200 million per quarter could create meaningful incremental operating profit, particularly if Teledyne can improve procurement, manufacturing utilization, overhead efficiency or product mix.

Does the $1.1bn valuation leave room for margin improvement?

Teledyne agreed to pay $18.90 per Varex share in cash, with the approximately $1.1 billion transaction value including equity awards and Varex net debt as of April 3. The merger is expected to close in early 2027, subject to Varex shareholder approval, regulatory clearance and customary conditions.

Annualising Varex’s latest reported $211 million quarter gives roughly $844 million of revenue, putting the transaction at about 1.3 times that simple annualised sales figure. That multiple alone does not establish whether the acquisition is cheap because earnings, cash conversion, growth and required capital all matter, but it highlights an important feature of the deal: Teledyne is not paying a high revenue multiple for a business already operating at Teledyne-like margins.

Instead, part of the potential value creation appears to reside in what happens after ownership changes. Varex’s latest quarter already showed improvement, with its non-GAAP operating margin at 12% and non-GAAP earnings per share of $0.31 versus $0.13 a year earlier.

Why Teledyne can tolerate some initial margin dilution

Teledyne enters the transaction from a comparatively strong financial position. It generated $284.7 million of free cash flow in the second quarter, repaid $450 million of gross debt during the period and ended June with net debt of approximately $1.69 billion and a consolidated leverage ratio of 1.1 times. The company also had about $1.16 billion available under its $1.2 billion credit facility.

That balance-sheet capacity gives Teledyne more room to prioritize strategic fit over immediate margin accretion. The acquisition adds X-ray tubes, flat-panel detectors, photon-counting detectors, high-voltage interconnects and imaging software to a Digital Imaging business that is already Teledyne’s largest segment.

Market pricing also suggests investors currently see relatively limited transaction-closing risk. Varex ended August 11 at $18.58, only about 1.7% below the $18.90 cash offer, while Teledyne closed at $681.74 after falling roughly 1.2% during the session. The narrow Varex spread incorporates both remaining deal risk and the time until the expected early-2027 completion.

For Teledyne, the more consequential test comes later. Varex can add roughly one-quarter to Digital Imaging’s latest quarterly revenue base on a simple comparison, but it arrives with substantially lower operating profitability. If Teledyne can narrow that gap, the acquisition becomes more than a portfolio expansion into photon counting and medical X-ray technology; it becomes a margin-conversion opportunity. If the gap persists, the additional scale could come with a visible drag on one of Teledyne’s strongest-performing businesses.